Real-time polymerase chain reaction analysis of MDM2 and CDK4 expression using total RNA from core-needle biopsies is useful for diagnosing adipocytic tumors
Taro Sasaki
0
Akira Ogose
0
Hiroyuki Kawashima
0
Tetsuo Hotta
0
Hiroshi Hatano
Takashi Ariizumi
Hajime Umezu
Riuko Ohashi
Tsuyoshi Tohyama
Naohito Tanabe
Naoto Endo
0
0
Division of Orthopedic Surgery, Niigata University Graduate School of Medical and Dental Sciences
,
757-1, Asahimachi-dori, Niigata City, Niigata 951-8510
,
Japan
Background: Diagnosing adipocytic tumors can be challenging because it is often difficult to morphologically distinguish between benign, intermediate and malignant adipocytic tumors, and other sarcomas that are histologically similar. Recently, a number of tumor-specific chromosome translocations and associated fusion genes have been identified in adipocytic tumors and atypical lipomatous tumors/well-differentiated liposarcomas (ALT/WDL), which have a supernumerary ring and/or giant chromosome marker with amplified sequences of the MDM2 and CDK4 genes. The purpose of this study was to investigate whether quantitative real-time polymerase chain reaction (PCR) could be used to amplify MDM2 and CDK4 from total RNA samples obtained from core-needle biopsy sections for the diagnosis of ALT/WDL. Methods: A series of lipoma (n = 124) and ALT/WDL (n = 44) cases were analyzed for cytogenetic analysis and lipoma fusion genes, as well as for MDM2 and CDK4 expression by real-time PCR. Moreover, the expression of MDM2 and CDK4 in whole tissue sections was compared with that in core-needle biopsy sections of the same tumor in order to determine whether real-time PCR could be used to distinguish ALT/WDL from lipoma at the preoperative stage. Results: In whole tissue sections, the medians for MDM2 and CDK4 expression in ALT/WDL were higher than those in the lipomas (P < 0.05). Moreover, karyotype subdivisions with rings and/or giant chromosomes had higher MDM2 and CDK4 expression levels compared to karyotypes with 12q13-15 rearrangements, other abnormal karyotypes, and normal karyotypes (P < 0.05). On the other hand, MDM2 and CDK4 expression levels in core-needle biopsy sections were similar to those in whole-tissue sections (MDM2: P = 0.6, CDK4: P = 0.8, Wilcoxon signed-rank test). Conclusion: Quantitative real-time PCR of total RNA can be used to evaluate the MDM2 and CDK4 expression levels in core-needle biopsies and may be useful for distinguishing ALT/WDL from adipocytic tumors. Thus, total RNA from core-needle biopsy sections may have potential as a routine diagnostic tool for other tumors where gene overexpression is a feature of the tumor.
-
Background
Adipocytic tumors represent the largest group of soft
tissue tumors [1]. The diagnosis of adipocytic tumors is
primarily based on clinical features and histologic patterns
[2]. However, the distinction between lipomas and atypical
lipomatous tumors/well-differentiated liposarcomas (ALT/
WDL) may be difficult to distinguish morphologically.
Cytogenetic studies of adipocytic tumors have
revealed a clear association between chromosomal
findings and clinicohistopathological features [3,4]. Clonal
chromosome aberrations have been found in nearly 60%
of all lipomas [4], of which two-thirds are
rearrangements involving the 12q13-15 chromosomal region. A
variety of rearrangements, mainly involving the 6p and
13q regions, are observed in the remaining lipoma cases
[5-7]. In tumors with aberrations involving 12q13-15
region, the high mobility group protein gene (HMGA2,
also known as HMGIC) on chromosome 12 is
rearranged. These aberrations may also result in the
creation of chimeric genes, in which the HMGA2 gene is
fused to multiple genes. The most frequent gene
aberration in lipomas is HMGA2/LPP [8].
ALT/WDL and dedifferentiated liposarcomas (DDL)
most often have a supernumerary ring and giant marker
chromosomes composed of amplified sequences from
the 12q13-15 region [9,10], including the murine
doubleminute type 2 gene (MDM2) and the cyclin-dependent
kinase 4 gene (CDK4) [11-13]. Amplification of the
12q1315 region has not been observed in lipoma, and the
MDM2 and CDK4 proteins are known to be overexpressed
in ALT/WDL but not in lipoma [14].
Immunohistochemistry for MDM2 and CDK4 plays a helpful role in the
differential diagnosis of adipocytic tumors. Aleixo et al. [15]
reported that MDM2 has very high sensitivity (100%) in
the identification of ALT/WDL among lipomas, but has
low specificity (58.8%), whereas CDK4 has low sensitivity
(68.4%), but high specificity (88.2%).
Immunohistochemistry may be used to demonstrate MDM2 and CDK4
amplification, but the sections sometimes show several staining
patterns such as diffuse, moderate, and focal positivity.
Categorization of these staining patterns has been
developed differently by different researchers, making it difficult
to compare studies effectively.
The use of minimally invasive biopsies to diagnose soft
tissue tumors has become increasingly common. On the
other hand, ALT/WDL can be difficult to distinguish
morphologically from benign lipomatous lesions, especially
with limited material in which the diagnostic features of
scattered atypical cells are not present because of
heterogeneity of the neoplasm. However, distinguishing benign
lipomatous tumors from ALT/WDL is important at
primary biopsy.
In this study, we used whole tissue sections from
surgically resected specimens to retrospectively analyze
cytogenetic findings by quantifying MDM2 and CDK4
expression levels in lipomas and ALT/WDL with
realtime polymerase chain reaction (PCR) from total RNA.
We evaluated the clinical utility of measuring MDM2
and CDK4 expression levels to establish a diagnosis of
adipocytic tumors, with the aim of making a distinction
between lipoma and ALT/WDL. Moreover, we
compared the results of MDM2 and CDK4 expression in
whole tissue sections with those in core-needle biopsy
sections in order to investigate whether real-time PCR
for MDM2 and CDK4 could be used to distinguish
between ALT/WDL and lipoma prior to surgery.
Methods
Specimens
Tumor samples were obtained from patients that
underwent surgical resection at Niigata University Hospital
between August 2001 and December 2012. In total, 124
cases of lipoma and 44 cases of ALT/WDL were studied
(Additional file 1: Table S1). In all cases, the diagnosis of
lipoma or ALT/WDL was established according to the
World Health Organization (WHO) Classification of
Tumors [2] by using hematoxylin and eosin-stained tissue
sections from the surgical resection specimens. Two
experienced pathologists independently reviewed the cases in
which it was difficult to distinguish between lipoma and
ALT/WDL. There were 159 primary and 9 recurrent
tumors. The patient cohort consisted of 96 men and 72
women between 24 and 86 years of age (mean 59.0 years;
range 2486 years).
The samples were taken from both core-needle biopsy
sections and whole tissue sections of the adipose tissue
tumors. Some of the samples represent paired whole
tissue sections and core-needle biopsy sections from the
same tumor. Core-needle biopsy sections were sampled
p (...truncated)